Clinical experience with recombinant factor VIIa in patients with thrombocytopenia.

Kristensen, J; Killander, A; Hippe, E; Helleberg, C; Ellegard, J; Holm, M; Kutti, J; Mellqvist, U H; Johansson, J E; Glazer, S; Hedner, U

Kristensen, J; Killander, A; Hippe, E; Helleberg, C; Ellegard, J; Holm, M; Kutti, J; Mellqvist, U H; Johansson, J E; Glazer, S; Hedner, U.

Affiliation

Kristensen J; Department of Medicine, Akademiska Sjukhuset Uppsala, Sweden.

Haemostasis ; 26 Suppl 1: 159-64, 1996.

Article in En | MEDLINE | ID: mdl-8904193

Subject(s)

Factor VIIa/therapeutic use; Thrombocytopenia/drug therapy; Adolescent; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Factor VIIa/adverse effects; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Recombinant Proteins/adverse effects; Recombinant Proteins/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thrombocytopenia / Factor VIIa Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Haemostasis Year: 1996 Document type: Article Affiliation country: Sweden

Search on Google

Add to My VHL

XML

PubMed Links